Senior Director - West International Cluster, Global Rare BU

Snr Director West International Cluster, Global Rare BU - Closing Date: November 13, 2027. This role will be responsible to develop and execute all sales and marketing activities in the relative cluster of countries, with immediate focus on driving the development of GIVLAARI and OXLUMO. This person will: Support and challenge regional and local teams in tailoring the global strategy to the specific markets while maintaining global/regional alignment; Allocate investment and drive and track focused execution of cross-functional tactics; Share learnings and best practices across the Global Rare Business Unit. The role will lead a team of Field Business Leaders (FBL) across a group of geographies and be the primary interface with local Country Managers and International TTR BU shared services (eg Regional Commercial, Business Operations and and Market Access). They will appropriately partner with Medical and Regional Marketing to ensure optimal alignment, insight sharing and communication. The Cluster Head will also build and execute the Cluster tactical plan (e.g.,Sales force and HCP target group prioritization, congress activities, marketing materials) and participate in the regional tactics as appropriate (e.g., European congresses). The Cluster Head reports to the VP, International Rare Head. Summary of Key Responsibilities Manages the full Commercial Team for the specific geographies (Field Business Leaders and their KAMs) Maximize the commercial potential of Alnylam’s assets through the development and implementation of strategic/operational plans in close collaboration with Global Rare marketing, Medical Affairs and Market Access teams. Define, plan and set the commercial direction for the business within the Cluster, utilizing innovative techniques to drive increased customer value and market penetration Lead the cross-functional team providing vision, motivation, and support and coaching infrastructure to drive the business and achieve portfolio objectives. Partner with Market Access and Country Managers to identify, develop, propose and execute local reimbursement plans, including alignment with appropriate adaptation of European pricing, reimbursement and access strategies Effectively lead and build a high performing commercial team by hiring top talent, addressing talent gaps, upskilling and providing career guidance Take responsibility and accountability to deliver against the agreed commercial and strategic objectives, as well as Quality, Compliance and risk management in the countries of the cluster Ensure that all business activities are in line with company policies, procedures and local guidelines Builds sustainable relationships with local healthcare stakeholders, functions as main partner for local customers and local/ international KOLs Ensure high quality revenue and volume forecasting and brand investment deployment for the cluster Develops and implements innovative, multichannel marketing strategies and tactics in the cluster, including the planning and tracking of commercial spent investment In close collaboration with the Global marketing teams, ensure deep local market and stakeholder insights to inform local tailoring of the strategy and tactics and to help inform the global/regional strategy Contributes to the development of the Global strategic plan and annual tactical plans. Ensure detailed pre-launch and post-launch tracking of agreed KPIs to allow early course correction and ensure execution of key tactics Qualifications, Key Skills, and Competencies Life Science degree or Business degree Extensive knowledge / experience of working in a bio/pharmaceutical commercial (Sales & Marketing) team Experience in collaboration in Cross-functional teams Demonstrable commercial leadership experience in the biopharmaceutical industry such as a highly successful Sales Manager or Marketing Manager and a strong sales & marketing leader within the specialty therapeutics arena, orphan drugs is a plus. Must have a track record of successful budget management with an understanding of revenue forecasting and expense budget planning and tracking Must have the ability to build and drive a business, whilst possessing innate ‘market-making’ capabilities with natural self-starter, hands-on, entrepreneurial and innovative attitude Strong leadership qualities such as having the ability to attract, motive and retain talent and drive a culture of collaboration, engagement and motivation Ability to provide strategic input at Global level Outstanding knowledge of the Rare Disease space, including Market Access key success factors. Strong network/matrix stakeholder communications skills with both regional and in-country teams Strong business and financial acumen Relentless external customer and patient focus Outstanding strategic thinking combined with strong execution leadership Inspirational leader, able to energize and motivate cross-functional teams and Sales Force Autonomous working style, pragmatic and operationally oriented, excellent planning and organizing skills Sense of urgency, ethics and responsibility Excellent command of written and spoken English Openness to travel approximately is required - 60% domestically and some internationally About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Before applying, please review Alnylam's ⁠Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment. #LI-CC1 #LI-Hybrid